Replimune Group, Inc. has 15 Schedule 13D or 13G filings on record since 2025-07-31. 6 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 11.8% | 11,075,336 | SCHEDULE 13D/A, 2026-08-11 | 2026-08-09 |
| RTW Investments, LP | 8.9% | 7,356,916 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Ridgeback Capital Investments L.P. | 8.7% | 7,310,656 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Montanova Capital, LLC | 7.9% | 6,609,000 | SCHEDULE 13G/A, 2026-08-06 | 2026-07-30 |
| State Street Corporation | 5.3% | 4,440,144 | SCHEDULE 13G, 2026-08-07 | 2026-06-30 |
| The Goldman Sachs Group, Inc. | 5.3% | 4,418,838 | SCHEDULE 13G, 2026-08-10 | 2026-06-30 |
| Point72 Asset Management, L.P. | 4.7% | 3,629,902 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Forbion Capital Fund III Cooperatief U.A. | 3.5% | 2,808,368 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Redmile Group, LLC | 0.7% | 535,818 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| T. Rowe Price Associates, Inc. | 0.2% | 157,965 | SCHEDULE 13G/A, 2026-05-07 | 2026-04-30 |
Purpose of Transaction (Item 4)
Baker Bros. Advisors LP
Item 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: The disclosures in Item 5 and Item 6 below are incorporated herein by reference. On August 9, 2026, Replimune Group, Inc. (the "Issuer") entered into an underwriting agreement (the "Underwriting Agreement") with Leerink Partners LLC, J.P. Morgan Securities LLC, and Cantor Fitzgerald & Co. (collectively, the "Underwriters"), related to the public offering (the "Offering") of 9,701,490 shares of common stock of the Issuer ("Common Stock") at a price to the public of $12.06 per share and 2,736,340 pre-funded warrants at a price to the public of $12.0599 per pre-funded warrant to purchase shares of Common Stock that are exercisable at any time on a 1-for-1 basis into Common Stock at an exercise price of $0.0001 per warrant with no expiration date, subject to beneficial ownership limitations described in Item 5 (the "2026 $0.0001 Prefunded Warrants"). The Offering closed on August 11, 2026. Pursuant to the Offering, 667 and Life Sciences purchased 126,394 and 2,609,946 2026 $0.0001 Prefunded Warrants, respectively, at the offering price of $12.0599 per pre-funded warrant, totaling 2,736,340 2026 $0.0001 Prefunded Warrants in the aggregate for an aggregate purchase price of $32,999,986.77. Each of 667 and Life Sciences purchased the 2026 $0.0001 Prefunded Warrants with its working capital. The Funds hold securities of the Issuer for investment purposes. The Reporting Persons or their …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-11; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-31 | Point72 Asset Management, L.P. | 5.7% | SCHEDULE 13G |
| 2025-11-14 | T. Rowe Price Associates, Inc. | 10.6% | SCHEDULE 13G/A |
| 2025-11-14 | Point72 Asset Management, L.P. | 4.7% | SCHEDULE 13G/A |
| 2025-11-14 | Redmile Group, LLC | 0.7% | SCHEDULE 13G/A |
| 2025-11-14 | RTW Investments, LP | 8.2% | SCHEDULE 13G |
| 2026-02-17 | Forbion Capital Fund III Cooperatief U.A. | 3.5% | SCHEDULE 13G/A |
| 2026-05-07 | T. Rowe Price Associates, Inc. | 0.2% | SCHEDULE 13G/A |
| 2026-05-12 | Suvretta Capital Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-05-15 | RTW Investments, LP | 8.9% | SCHEDULE 13G/A |
| 2026-05-21 | Ridgeback Capital Investments L.P. | 7.6% | SCHEDULE 13G |
| 2026-08-06 | Montanova Capital, LLC | 7.9% | SCHEDULE 13G/A |
| 2026-08-07 | State Street Corporation | 5.3% | SCHEDULE 13G |
| 2026-08-10 | The Goldman Sachs Group, Inc. | 5.3% | SCHEDULE 13G |
| 2026-08-11 | Baker Bros. Advisors LP | 11.8% | SCHEDULE 13D/A |
| 2026-08-14 | Ridgeback Capital Investments L.P. | 8.7% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Replimune Group, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.